Location: San Francisco, CA
CIK: 0001833486 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 18, 2026
Total Value: $101M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Surrozen, Inc. | 1,916,950 (+3.5%) | $55.84M (+33.5%) | 55.4% | $12.64 | — | COM | 86889P109 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TNYA | Tenaya Therapeutics, Inc. | 9,400,290 | $6.693M | 6.6% | $21.49 | -96.6% | — | 87990A106 |
| — | RAPT Therapeutics Inc | 156,270 | $5.293M | 5.3% | $19.03 | — | — | 75382E109 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ORIC | ORIC Pharmaceuticals Inc. | 3,540,777 | $44.86M | 44.5% | $28.69 | -62.5% | COM | 68622P109 |
| RVMD | Revolution Medicines Inc | 46 | $4,474 | 0.0% | $34.24 | +200.8% | COM | 76155X100 |